Showing results (601-610 of 3,703) with videos related to
Sort By:
Pageof 371
Pharmacology & Therapeutics|April 26, 2021
Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosisShuai Shao, Chengjuan Chen, Gaona Shi, et al.Pharmacology & Therapeutics|April 26, 2021
Dietary nutrition for neurological disease therapy: Current status and future directionsXiao-Yuan Mao, Xi-Xi Yin, Qi-Wen Guan, et al.Pharmacology & Therapeutics|April 1, 2023
ORMDL in metabolic health and diseaseRyan D R Brown, Sarah SpiegelPharmacology & Therapeutics|March 31, 2023
The pathomimetic oAβ25-35 model of Alzheimer's disease: Potential for screening of new therapeutic agentsGeoffrey Canet, Charleine Zussy, Célia Hernandez, et al.Pharmacology & Therapeutics|March 31, 2023
The implication of anti-PD-1 therapy in cancer patients for the vaccination against viral and other infectious diseasesSruthi Vijaya Retnakumar, Camille Chauvin, Jagadeesh BayryPharmacology & Therapeutics|June 24, 2008
WITHDRAWN: Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectivesMaria Luigia Fazia, Andrea Mezzetti, Francesco CipollonePharmacology & Therapeutics|January 1, 1991
Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapyA MeisterPharmacology & Therapeutics|January 1, 1991
Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubulesR H HimesPharmacology & Therapeutics|June 20, 2008
Nucleotides in ocular secretions: their role in ocular physiologyAlmudena Crooke, Ana Guzmán-Aranguez, Assumpta Peral, et al.Pharmacology & Therapeutics|June 9, 2006
Bioactive sphingolipids in the modulation of the inflammatory responseMazen El Alwani, Bill Xingjun Wu, Lina M Obeid, et al.Pageof 371